2-AMINO-7,8-DIHYDRO-6H-PYRIDO[4,3-D] PYRIMIDIN-5-ONES

Disclosed are 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5...

Full description

Saved in:
Bibliographic Details
Main Authors LEVINE, BARRY H, LIN, XIAODONG, POON, DANIEL, MCBRIDE, CHRISTOPHER, GAO, ZHENHAI, COSTALES, ABRAN, RICO, ALICE, BRAMMEIER, NATHAN, DOLAN, JOHN, BARSANTI, PAUL A, MACHAJEWSKI, TIMOTHY D, DOUGHAN, BRANDON M, GONG, BAOQING, PICK, TERESA, MENDENHALL, KRIS, ANTONIOS-MCCREA, WILLIAM, WANG, X. MICHAEL, BRINNER, KRISTIN, TULINSKY, JOHN, ZHOU, YASHEEN, MCKENNA, MAUREEN, GU, DAN, SHAFER, CYNTHIA M, XIA, YI, RENHOWE, PAUL A
Format Patent
LanguageEnglish
French
Published 16.06.2015
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Disclosed are 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, their stereoisomers, tautomers, pharmaceutically acceptable salts, and prodrugs thereof; compositions that include a pharmaceutically acceptable carrier and one or more of the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent. Disclosed also are methods of using the 2-amino-7,8-dihydro-6H-pyrido[4,3-d]pyrimidin-5-one compounds, either alone or in combination with at least one additional therapeutic agent, in the prophylaxis or treatment of cellular proliferative, viral, autoimmune, cardiovascular, and central nevous system diseases.
Bibliography:Application Number: CA20062624253